Synergism from Combination of Cisplatin and Multicentred Platinums Coded as DH6Cl and TH1 in the Human Ovarian Tumour Models

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|7|6|593-598

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.7, Iss.6, 2011-11, pp. : 593-598

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination gemcitabine + cisplatin therapy for recurrent ovarian cancer

By  

Inpharma, Vol. 1, Iss. 1376, 2003-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study

By Morgan Robert  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 723-728

Springer Publishing Company

Access to resources Recommend Favorite

Role of Pemetrexed and Platinums Combination in Patients with Non- Small Cell Lung Cancer

By  

Current Drug Targets, Vol. 11, Iss. 1, 2010-01 ,pp. : 29-36

Bentham Science Publishers

Access to resources Recommend Favorite

Th1-mediated Pathology in Mouse Models of Human Disease is Ameliorated by Concurrent Th2 Responses to Parasite Antigens

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 5, 2004-02 ,pp. : 531-538

Bentham Science Publishers

Access to resources Recommend Favorite

Synthetic Naphthoflavonoids Showing Inhibitory Effects on Clonogenicity against Cisplatin-Resistant A2780/Cis Human Ovarian Cancer Cells

By  

Letters in Drug Design & Discovery, Vol. 12, Iss. 8, 2015-10 ,pp. : 628-639

Bentham Science Publishers

Access to resources Recommend Favorite